Vice President, Corporate Development & Strategy
Dr. Stamoran has spent nearly 25 years engaged with the healthcare industry, and has experienced the realities of patient adherence and outcomes enhancement from almost every stakeholder perspective: from direct engagement with retail and hospital pharmacists; medical professionals; specialty pharmacies and clinics; and pharmacy benefit managers and payers. He has directly participated in adherence and outcomes enhancement strategies for more than 150 drugs over the last 10 years.
Director, Technology Development
After receiving his B.Sc degree in Biochemistry from Cardiff University, Wales, Mr. Stroud spent 9 years working at the Pharmaceutics Department, School of Pharmacy and Pharmacology, University of Bath, England. During his time in Academia, he held various positions in Pharmaceutical R&D, with a focus on the development of liquid dosage forms. In 1982 Norman joined the R&D group of R.P. Scherer UK and held various scientific and managerial positions while working in the field of softgel encapsulation. After transferring to the St. Petersburg, Florida facility in 1991, he continued to work on formulation and process development of softgels, with a focus on product innovation. He has been granted 9 US patents. During his time at Catalent Pharma Solutions (formerly R.P. Scherer/Cardinal Health) Norman has held a variety of functional and leadership roles. His more recent research studies have focused on the use of polysaccharide-based capsule shells for the encapsulation of pharmaceutical fill formulations. He is currently Director of Technology Development at the Catalent Pharma Solutions facility in St. Petersburg.